Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Embryonic stem cells (ESCs) can be used as a source of cellular models for a wide range of adult differentiated cells, providing that reliable differentiation protocols are established. Here, Pouton and Haynes discuss challenges and opportunities regarding the use of ESC-derived models for drug discovery.
The intrinsic robustness of biological systems is a key factor preventing the success of potential drugs that target specific molecules. Using examples based on existing drugs, Kitano discusses how a greater consideration of the importance of robustness could influence the design of new drugs intended to control complex systems.